Founded in 1888 in New York, Willkie Farr & Gallagher is best known for its work in private equity and investment funds, especially regarding M&A. The firm has also since expanded to 12 offices across the United States and Europe, with six of those offices being in the United States. The New York office remains the hub for the firm’s operations and is its largest office.
In addition to its strengths in private equity, registered funds and hedge funds, the firm also does notable work in banking, project development and restructuring and insolvency.
The banking practice acts for borrowers and lenders in acquisition financing, refinancing, project financing and general working capital financing.
In M&A, the practice acts on both the buy and sell side in private equity and strategic acquisitions, mergers, privatizations and joint ventures. The team most often acts for private equity firms in acquisition matters. The firm also has a private equity team that works on acquisitions, privatizations, recapitalizations and financial investments.
The project development team represents sponsors and developers in projects in the oil and gas, renewable energy and transportation infrastructure industries. It also represents buyers and sellers in project related acquisitions.
In the restructuring and insolvency practice, the firm represents creditors and debtors in out of court financial restructurings, Chapter 11 proceedings and distressed M&A matters.
Many, but not all, of Willkie Farr & Gallagher’s clients are private equity firms. Key clients for the firm include FIS, Insight Partners, CenturyLink, Genstar Capital, HealthEquity, Centerview Partners, Colony Capital, AIG, Aquiline Capital Partners, Aegerion Pharmaceuticals, Aralez Pharmaceuticals, Glansaol Holdings and Brookfield Business Partners.